Company Profile
International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation (NASDQ:THOR) is a world leader in the fields of hemostasis management and point-of-care testing with over 39 years of knowledge and experience. ITC develops, manufactures and markets products in six distinct categories: Hemochron® point-of-care coagulation instruments and reagents; IRMA TruPoint® Blood Analysis System for blood gas and electrolyte testing; Avoximeter® provides rapid, accurate oximetry and co-oximetry assessment; skin incision products including Tenderfoot®, Tenderlett® and Surgicutt®; HgbPro Professional Hemoglobin Testing System®; and the ProTime® Microcoagulation System for prothrombin time patient self-testing and for professional use.
Company Management
Lawrence Cohen - President
Gregory Colella - Vice President, Research and Development
Brett Giffin - Vice President, Sales, Marketing and Business Development
Alex Bourdon - Vice President, Manufacturing Operations
Diane Norton - Vice President, Manufacturing Operations and Roseville Site Manager
Marta Chase - Vice President, Quality, Regulatory and Clinical Affairs
Larry Wojcik - Vice President, Finance
International Technidyne Corporation (ITC), a wholly owned subsidiary of Thoratec Corporation (THOR on NASDAQ), is a worldwide leader in the development, manufacturing, and marketing of point-of-care hemostasis management products for use in hospitals, physician's offices, and the home.
With the past 40 years of point-of-care excellence to share, ITC is a worldwide leader in the fields of coagulation management and point-of-care testing.